Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Observational Safety and Efficacy Study in Subjects Using Insulin for the Treatment of Type 2 Diabetes Mellitus Failing on Oral Anti-diabetic Agents

NCT00715780 is registered in ClinicalTrials.gov with Novo Nordisk A/S as lead sponsor.

NCT NCT00715780
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00715780 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Observational Safety and Efficacy Study in Subjects Using Insulin for the Treatment of Type 2 Diabetes Mellitus Failing on Oral Anti-diabetic Agents
Lead sponsor
Novo Nordisk A/S
Phase
Observational
Overall status
Completed
Start date
June 30, 2008
Completion date
July 31, 2009
Enrollment
1,667 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes, diabetes mellitus, type 2